322 related articles for article (PubMed ID: 32077253)
61. Safety and Cost-effectiveness of Outpatient Administration of High-dose Chemotherapy in Children With Ewing Sarcoma.
Elshahoubi A; Alnassan A; Sultan I
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e152-e154. PubMed ID: 30608490
[TBL] [Abstract][Full Text] [Related]
62. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
[TBL] [Abstract][Full Text] [Related]
63. Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group.
Umeda K; Miyamura T; Yamada K; Sano H; Hosono A; Sumi M; Okita H; Kamio T; Maeda N; Fujisaki H; Jyoko R; Watanabe A; Hosoya Y; Hasegawa D; Takenaka S; Nakagawa S; Chin M; Ozaki T;
Pediatr Blood Cancer; 2021 Mar; 68(3):e28844. PubMed ID: 33340261
[TBL] [Abstract][Full Text] [Related]
64. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S
J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532
[TBL] [Abstract][Full Text] [Related]
65. Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
DuBois SG; Krailo MD; Glade-Bender J; Buxton A; Laack N; Randall RL; Chen HX; Seibel NL; Boron M; Terezakis S; Hill-Kayser C; Hayes A; Reid JM; Teot L; Rakheja D; Womer R; Arndt C; Lessnick SL; Crompton BD; Kolb EA; Daldrup-Link H; Eutsler E; Reed DR; Janeway KA; Gorlick RG
J Clin Oncol; 2023 Apr; 41(11):2098-2107. PubMed ID: 36669140
[TBL] [Abstract][Full Text] [Related]
66. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
[TBL] [Abstract][Full Text] [Related]
67. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
[TBL] [Abstract][Full Text] [Related]
68. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
Marina NM; Pappo AS; Parham DM; Cain AM; Rao BN; Poquette CA; Pratt CB; Greenwald C; Meyer WH
J Clin Oncol; 1999 Jan; 17(1):180-90. PubMed ID: 10458232
[TBL] [Abstract][Full Text] [Related]
69. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
[TBL] [Abstract][Full Text] [Related]
70. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.
Arpaci E; Yetisyigit T; Seker M; Uncu D; Uyeturk U; Oksuzoglu B; Demirci U; Coskun U; Kucukoner M; Isıkdogan A; Inanc M; Alkis N; Ozkan M
Med Oncol; 2013 Mar; 30(1):469. PubMed ID: 23345116
[TBL] [Abstract][Full Text] [Related]
71. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.
Ladenstein R; Pötschger U; Le Deley MC; Whelan J; Paulussen M; Oberlin O; van den Berg H; Dirksen U; Hjorth L; Michon J; Lewis I; Craft A; Jürgens H
J Clin Oncol; 2010 Jul; 28(20):3284-91. PubMed ID: 20547982
[TBL] [Abstract][Full Text] [Related]
72. Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
Mora J; de Torres C; Parareda A; Torner F; Galván P; Rodríguez E; Cardesa T; Salvador H; Suñol M; Huguet R; Cruz O
Pediatr Blood Cancer; 2011 Jul; 57(1):69-75. PubMed ID: 21384537
[TBL] [Abstract][Full Text] [Related]
73. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
[TBL] [Abstract][Full Text] [Related]
74. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
[TBL] [Abstract][Full Text] [Related]
75. [Therapy results of the British ET-1 study for Ewing's sarcoma].
Dunst J
Strahlenther Onkol; 1998 May; 174(5):289-90. PubMed ID: 9614962
[No Abstract] [Full Text] [Related]
76. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Jürgens H; Exner U; Kühl J; Ritter J; Treuner J; Weinel P; Winkler K; Göbel U
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S40-4. PubMed ID: 2503258
[TBL] [Abstract][Full Text] [Related]
77. Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP).
Deméocq F; Oberlin O; Benz-Lemoine E; Boilletot A; Gentet JC; Zucker JM; Behar C; Poutard P; Olive D; Brunat-Mentigny M
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S45-7. PubMed ID: 2667789
[TBL] [Abstract][Full Text] [Related]
78. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience.
Rosito P; Mancini AF; Rondelli R; Abate ME; Pession A; Bedei L; Bacci G; Picci P; Mercuri M; Ruggieri P; Frezza G; Campanacci M; Paolucci G
Cancer; 1999 Aug; 86(3):421-8. PubMed ID: 10430250
[TBL] [Abstract][Full Text] [Related]
79. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
[TBL] [Abstract][Full Text] [Related]
80. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Luksch R; Tienghi A; Hall KS; Fagioli F; Picci P; Barbieri E; Gandola L; Eriksson M; Ruggieri P; Daolio P; Lindholm P; Prete A; Bisogno G; Tamburini A; Grignani G; Abate ME; Podda M; Smeland S; Ferrari S
Ann Oncol; 2012 Nov; 23(11):2970-2976. PubMed ID: 22771824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
